Pages

Sunday, July 21, 2013

Question of the Day July 21, 2013 What Action Should the FDA and State Boards of Pharmacies Be Taking Against the Makers of Purple Pain and TB-500 in ligh t of the Racing Medication and Testing Consortium finding these are unclassified medications that will be regarded as high-level violations if used in racing? Who is the company producing these drugs? How Many of these Products are being sold in the United States?

Background as previously posted:  The Racing Medication and Testing Consortium has noted that two substances available only through compounding pharmacies are unclassified medications that will be regarded as high-level violations if used in racing. 

 Purple Pain is marketed as a pain reliever. TB-500 is claimed by some marketing materials to build muscle, speed muscle recovery, stop bleeding, increase red blood cells, and decrease inflammation.

Read more on BloodHorse.com: http://www.bloodhorse.com/horse-racing/articles/79187/stiff-penalties-tied-to-purple-pain-tb-500#ixzz2ZezcLpNL